Videos / Weight management and cardiovascular risk reduction: The role of Semaglutide 2.4mg
In this Product Explainer, Dr. Robert Hungerford, GP with a special interest in ASCVD, heart failure and diabetes, explains the role of Semaglutide 2.4mg in weight management and cardiovascular risk reduction in secondary prevention (7 mins).

The Natural Estrogen Debate: A Focus on Combined Oral Contraception

Panel Discussion on GLP1s for Chronic Kidney Disease in Type 2 Diabetes

Eczema Management Practical Tips

Menopausal Hormone Therapy and its Cardiovascular Benefits

expert
GP Supervisor with a special interest in Heart Failure, ASCVD and Diabetes, Marketown Health; Conjoint lecturer, University of Newcastle